This site is intended for healthcare professionals
Industry news

Allergan acquires Motus Therapeutics and with it, relamorelin (RM-131) for the treatment of gastroparesis

Read time: 1 mins
Last updated:1st Nov 2016
Published:1st Nov 2016
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest